Sponsor

Tibotec Pharmaceutical Limited

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Tibotec Pharmaceutical Limited appears in 12 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials12
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

12 shown
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment AdherenceNCT01369056 · collaborator · 2010-07-01
COMPLETED
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIVNCT00983853 · collaborator · 2009-10-01
COMPLETED
A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected ChildrenNCT00919854 · collaborator · 2009-09-01
COMPLETED
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected AdolescentsNCT00915655 · collaborator · 2009-07-01
COMPLETED
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal TissueNCT00855088 · collaborator · 2009-07-01
COMPLETED
Strategic Timing of Antiretroviral TreatmentNCT00867048 · collaborator · 2009-04-15
COMPLETED
Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive PatientsNCT00677300 · collaborator · 2009-01-01
COMPLETED
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/rNCT00756730 · collaborator · 2008-09-01
COMPLETED
Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136NCT00421551 · collaborator · 2007-03-01
COMPLETED
Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerNCT00303108 · collaborator · 2005-12-01
COMPLETED
Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in BelgiumNCT00332995 · collaborator · 2005-07-01
COMPLETED
Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)NCT00700284 · collaborator · 2004-10-01
COMPLETED

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Tibotec Pharmaceutical Limited as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
darunavir5
ritonavir5
abacavir1
carboplatin1
etravirine1
lamivudine1
raltegravir1
trastuzumab1

Sponsor roles

collaborator12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.